Which hedge funds own MDGL? MADRIGAL PHARMACEUTICALS INC, Q2 2026 13F holders
61 tracked hedge funds disclosed a position in MDGL (MADRIGAL PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $4.6bn in total. The largest holder by portfolio weight is RTW Investments, LP at 9.1% of its book. 26 opened a new position this quarter: Jones Hill Capital LP, Scientech Research LLC, Holocene Advisors, LP, Weiss Asset Management LP. 12 exited: Logos Global Management LP, Eversept Partners, LP, Landscape Capital Management, L.L.C..
- 61
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 26
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 12
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $194m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $168m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $4.6bn
- Combined value Sum of the holders' reported positions in the security.
- 4.9%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Logos Global Management LP | 2.3% | $44.5m |
| Eversept Partners, LP | 0.3% | $5.2m |
| Landscape Capital Management, L.L.C. | 0.3% | $4.4m |
| Adage Capital Partners GP, L.L.C. | 0.1% | $97.0m |
| Entropy Technologies, LP | 0.1% | $2.9m |
| AlphaGrep UK Ltd | 0.1% | $397k |
| Dark Forest Capital Management LP | 0.04% | $486k |
| Walleye Capital LLC | 0.04% | $6.9m |
| Magnetar Financial LLC | 0.02% | $2.0m |
| Farallon Capital Management, L.L.C. | 0.01% | $1.7m |
| Voleon Capital Management LP | 0.01% | $430k |
| Bridgewater Associates, LP | 0.01% | $2.1m |
Ownership over time
Who discovered MDGL first? Beta
The run: Q2 2017 → Q2 2018, ×17
| Armistice Capital, LLC | Q3 2017 | 0.8% | +9.2 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.